We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Teva Pharmaceutical Industries Ltd | TG:TEV | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|
0.10 | 0.62% | 16.25 | 3,643 | 08:57:59 |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
16.15 | 16.30 | 16.25 | 16.10 | 16.10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | USD 15.85B | USD -559M | USD -0.4934 | -36.48 | 18.3B |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
08:56:25 | 622 | 16.25 | EUR |
Date | Time | Source | Headline |
---|---|---|---|
08/11/2024 | 21:30 | UKREG | Teva to Present at the Jefferies London Healthcare Conference |
06/11/2024 | 12:00 | UKREG | Teva Announces Strong Financial Results for the Third Quarter of 2024, led.. |
01/11/2024 | 19:05 | UKREG | Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the.. |
01/11/2024 | 19:00 | UKREG | Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3.. |
31/10/2024 | 11:29 | UKREG | Teva Statement on European Commission Decision; Company to Appeal |
22/10/2024 | 11:00 | UKREG | Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of.. |
08/10/2024 | 11:00 | UKREG | Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by.. |
03/10/2024 | 12:30 | UKREG | Teva and mAbxience Expand Strategic Partnership to include an additional.. |
01/10/2024 | 12:29 | UKREG | Teva Announces Launch of the First and Only Generic Version of Sandostatin®.. |
30/9/2024 | 20:30 | UKREG | Teva to Host Conference Call to Discuss Third Quarter 2024 Financial.. |
Teva Pharmaceutical Indu... (TEV) Share Charts1 Year Teva Pharmaceutical Indu... Chart |
|
1 Month Teva Pharmaceutical Indu... Chart |
Intraday Teva Pharmaceutical Indu... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions